Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of developing symptoms was cut in half, according to a new srudy.

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Eisai Co.’s breakthrough Alzheimer’s drug Leqembi was cleared for use in the European Union, after the medicine was approved ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...